In major step toward the clinic, Ring’s human viral vector delivers gene therapy to eyes of mice
Ring Therapeutics’ hunt for new human viruses that can deliver gene therapies multiple times in a single patient appears to have landed on a viable candidate, new mouse data have suggested.